Virtual Investor is a leading platform providing investors with direct access to innovative companies, management teams and thought leaders.

Upcoming Live Events

Covered Companies

Covered Companies

Series

What This Means

Featuring: Moleculin Biotech
June 18, 2025

Walter Klemp, Founder, President, CEO and Chairman of Moleculin, discussed the Company’s recently announced positive FDA feedback received on the Pediatric Study Plan for Annamycin in children with relapsed/refractory acute myeloid leukemia (R/R AML).

What This Means

Featuring: Senti Bio
June 18, 2025

Senti Bio Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202 to Treat Acute Myeloid Leukemia

What This Means

Featuring: Moleculin
June 11, 2025

Globally recognized Oncology Key Opinion Leader, Brian Andrew Van Tine, MD, PhD, discusses the positive topline results from the U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue Sarcoma Lung Metastases (MB-107)

What This Means

Featuring: Veru
May 28, 2025

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

What This Means

Featuring: Palisade Bio
May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

CEO Connect

Featuring: Autonomix Medical
May 13, 2025

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling  Addressable Market

Past Events

Past Events

Join Us

Sign up for email alerts to stay up-to-date on the latest Virtual Investor events


By submitting this form, you are consenting to receive marketing emails from: Virtual Investor. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

If you are interested in joining our roster of covered companies and participating in our events, sign up here: